
Sunshine Biopharma Inc.: shareholders and insiders
Price
$2.60
November 16, 2026Market cap $2.1M
What Ploutos Investor adds for Sunshine Biopharma
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 17, 2025 to Aug 11, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
- Aug 7, 2026David NatanDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | David NatanDirector | 58.3K | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by SBFM's officers and directors from 2012 up to November 16, 2025, 14 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 9 more, back to 2012
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Mitchell P. Kopinwith 2 more personsShare of class9.99%
- CVI Investments, Inc.with 1 more personShare of class9.90%
- Bigger Capital Fund L Pwith 6 more personsShare of class9.47%
- BJI Financial GroupShare of class6.00%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Mitchell P. Kopinwith 2 more persons | 9.99% | 430.3K | Nov 10, 20263 filings since May 23, 2025 | 13G/A | |
| CVI Investments, Inc.with 1 more person | 9.90% | 1.59M | Oct 13, 2026 | 13G | |
| Bigger Capital Fund L Pwith 6 more persons | 9.47% | 1.61M | May 21, 20263 filings since Apr 11, 2025 | 13G | |
| BJI Financial Group | 6.00% | 909.9K | Oct 14, 2026 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
No well-known manager
None of the managers we track held Sunshine Biopharma shares in their latest 13F.
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 840.9K shares were held short, +539.6% since the report before.
- Shares held short
- 840.9K
- Since the report before131.5K on Sep 30, 2026
- +539.6%
- under 1
- 28.79M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 3%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 135.1K
- Nov 15, 2023: Shares held short 95.6K
- Nov 30, 2023: Shares held short 74.1K
- Dec 15, 2023: Shares held short 60.2K
- Dec 29, 2023: Shares held short 114.7K
- Jan 12, 2024: Shares held short 112.9K
- Jan 31, 2024: Shares held short 102.6K
- Feb 15, 2024: Shares held short 602.6K
- Feb 29, 2024: Shares held short 445.3K
- Mar 15, 2024: Shares held short 971.0K
- Mar 28, 2024: Shares held short 706.7K
- Apr 15, 2024: Shares held short 6.98M
- Apr 30, 2024: Shares held short 284.5K
- May 15, 2024: Shares held short 176.3K
- May 31, 2024: Shares held short 157.8K
- Jun 14, 2024: Shares held short 1.57M
- Jun 28, 2024: Shares held short 852.2K
- Jul 15, 2024: Shares held short 360.9K
- Jul 31, 2024: Shares held short 472.3K
- Aug 15, 2024: Shares held short 216.2K
- Aug 30, 2024: Shares held short 245.3K
- Sep 13, 2024: Shares held short 222.3K
- Sep 30, 2024: Shares held short 370.9K
- Oct 15, 2024: Shares held short 321.5K
- Oct 31, 2024: Shares held short 374.1K
- Nov 15, 2024: Shares held short 234.1K
- Nov 29, 2024: Shares held short 555.6K
- Dec 13, 2024: Shares held short 474.2K
- Dec 31, 2024: Shares held short 217.9K
- Jan 15, 2025: Shares held short 78.2K
- Jan 31, 2025: Shares held short 83.5K
- Feb 14, 2025: Shares held short 57.5K
- Feb 28, 2025: Shares held short 63.5K
- Mar 14, 2025: Shares held short 113.1K
- Mar 31, 2025: Shares held short 141.3K
- Apr 15, 2025: Shares held short 122.0K
- Apr 30, 2025: Shares held short 395.5K
- May 15, 2025: Shares held short 259.0K
- May 30, 2025: Shares held short 153.9K
- Jun 13, 2025: Shares held short 94.9K
- Jun 30, 2025: Shares held short 89.6K
- Jul 15, 2025: Shares held short 305.9K
- Jul 31, 2025: Shares held short 295.7K
- Aug 15, 2025: Shares held short 288.3K
- Aug 29, 2025: Shares held short 248.0K
- Sep 15, 2025: Shares held short 218.5K
- Sep 30, 2025: Shares held short 208.6K
- Oct 15, 2025: Shares held short 364.9K
- Oct 31, 2025: Shares held short 921.2K
- Nov 14, 2025: Shares held short 589.5K
- Nov 28, 2025: Shares held short 430.3K
- Dec 15, 2025: Shares held short 393.6K
- Dec 31, 2025: Shares held short 334.1K
- Jan 15, 2026: Shares held short 307.2K
- Jan 30, 2026: Shares held short 281.3K
- Feb 13, 2026: Shares held short 235.2K
- Feb 27, 2026: Shares held short 225.8K
- Mar 13, 2026: Shares held short 166.4K
- Mar 31, 2026: Shares held short 140.0K
- Apr 15, 2026: Shares held short 134.4K
- Apr 30, 2026: Shares held short 104.1K
- May 15, 2026: Shares held short 496.1K
- May 29, 2026: Shares held short 1.44M
- Jun 15, 2026: Shares held short 174.7K
- Jun 30, 2026: Shares held short 113.5K
- Jul 15, 2026: Shares held short 62.5K
- Jul 31, 2026: Shares held short 126.4K
- Aug 14, 2026: Shares held short 73.9K
- Aug 31, 2026: Shares held short 86.9K
- Sep 15, 2026: Shares held short 23.4K
- Sep 30, 2026: Shares held short 131.5K
- Oct 15, 2026: Shares held short 840.9K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading51.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 51.7% of the shares in the reported trades were short sales, against 54.9% in the 14 before.
- Last 14 sessionsOct 28, 2026 – Nov 16, 2026
- 51.7%
- The 14 beforeOct 8, 2026 – Oct 27, 2026
- 54.9%
- Change
- -3.2 pts
- Short sales a dayon average, of 35.2K shares
- 18.2K
- More than atof 3,668 US-listed companies, same days
- 56%
- Median of alleight in ten from 34.7% to 63.8%
- 50.3%
- Short sales
- Oct 8, 2026: Short sales 57.1%
- Oct 9, 2026: Short sales 61.2%
- Oct 12, 2026: Short sales 48.6%
- Oct 13, 2026: Short sales 35.4%
- Oct 14, 2026: Short sales 41.2%
- Oct 15, 2026: Short sales 57.7%
- Oct 16, 2026: Short sales 44.4%
- Oct 19, 2026: Short sales 58.1%
- Oct 20, 2026: Short sales 19.2%
- Oct 21, 2026: Short sales 36.1%
- Oct 22, 2026: Short sales 62%
- Oct 23, 2026: Short sales 60.9%
- Oct 26, 2026: Short sales 55.8%
- Oct 27, 2026: Short sales 65.1%
- Oct 28, 2026: Short sales 54.6%
- Oct 29, 2026: Short sales 70.7%
- Oct 30, 2026: Short sales 55.9%
- Nov 2, 2026: Short sales 52.8%
- Nov 3, 2026: Short sales 56.3%
- Nov 4, 2026: Short sales 36.6%
- Nov 5, 2026: Short sales 52.9%
- Nov 6, 2026: Short sales 61.7%
- Nov 9, 2026: Short sales 43.5%
- Nov 10, 2026: Short sales 56.5%
- Nov 11, 2026: Short sales 37%
- Nov 12, 2026: Short sales 45.9%
- Nov 13, 2026: Short sales 12.6%
- Nov 16, 2026: Short sales 38.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- David NatanDirectorDirectly68.3K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| David NatanDirector | 68.3K | – | Aug 7, 2026 | Form 4 |
A lower bound: it counts only the 1 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 14
- Q4 2025: Managers 13
- Q1 2026: Managers 12
- Q2 2026: Managers 9
Institutional investors by quarter
The fund managers holding SBFM, quarter by quarter, from Q4 2021 to Q2 2025, 14 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 9 managers held 15.5K shares, worth $32.6K. During the quarter 9 opened a position, 0 closed one, 0 added and 0 trimmed.
The largest holders, Q2 2026
- Jane Street GroupIn the quarter
- Morgan StanleyIn the quarter
- SBI SecuritiesIn the quarter
- National Bank of CanadaIn the quarter
- Osaic HoldingsIn the quarter
- Strive Financial GroupIn the quarter
- TD Waterhouse CanadaIn the quarter
- Farther Finance AdvisorsIn the quarter
- Caitong International Asset ManagementIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Jane Street Group | 15.0K | $31.4K | |
| Morgan Stanley | 385 | $808 | |
| SBI Securities | 162 | $340 | |
| National Bank of Canada | 5 | $10 | |
| Osaic Holdings | 2 | $4 | |
| Strive Financial Group | 1 | $2 | |
| TD Waterhouse Canada | 1 | $2 | |
| Farther Finance Advisors | 1 | $2 | |
| Caitong International Asset Management | 1 | $2 |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Sunshine Biopharma's filings show?
Who buys and sells is one part of Sunshine Biopharma's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have SBFM's insiders bought or sold?
From Aug 11, 2026 to Aug 11, 2026 Sunshine Biopharma's insiders reported no purchase or sale of shares on the market.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.